The Oncosearch | Oncotarget

Cathepsin L secretion by host and neoplastic cells potentiates invasion Research Paper

Samantha S. Dykes, Henrietta O. Fasanya, Dietmar W. Siemann

Published Aug 27, 2019

Keywords: breast cancer, macrophage, invasion, cathepsin L

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database Clinical Research Papers

Jie Zhang, Xiao-Xiao Wang, Jun-Yu Lian, Chuan-Gui Song

Published Aug 27, 2019 · Vol. 10, No. 50 · pp. 5245-5252

Nicotinamide in the prevention of breast cancer recurrences? Editorial

Giulia Dell’Omo, Paolo Ciana

Published Aug 20, 2019 · Vol. 10, No. 53 · pp. 5495-5496

Keywords: chemoprevention, SIRT1 inhibitors, mammary cancer, NSAIDs

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer Research Paper

Nicci Owusu-Brackett, Kurt W. Evans, Argun Akcakanat, Erkan Yuca, Coya Tapia, Yasmeen Qamar Rizvi, Ecaterina Ileana Dumbrava, Filip Janku, Funda Meric-Bernstam

Published Aug 20, 2019 · Vol. 10, No. 49 · pp. 5011-5019

Keywords: breast cancer, TAK228, PI3K, PTEN, TNBC

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis Research Perspective

Chong Gao, Gu Xiao, Jill Bargonetti

Published Aug 20, 2019 · Vol. 10, No. 49 · pp. 5007-5010

Keywords: MDMX, MDM4, mutant p53, mtp53, metastasis

Vascular endothelium function among male carriers of BRCA 1&2 germline mutation Research Paper

Guy Witberg, Eli Lev, Yaara Ber, Tzlil Tabachnik, Sivan Sela, Ira Belo, Dorit Leshem-Lev, David Margel

Published Aug 20, 2019 · Vol. 10, No. 49 · pp. 5041-5051

Keywords: BRCA, DNA repair, endothelial progenitor cells, vascular endothelium damage, cardiovascular system

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy Correction

Annalisa Petrelli, Rosachiara Carollo, Marilisa Cargnelutti, Flora Iovino, Maurizio Callari, Daniela Cimino, Matilde Todaro, Laura Rosa Mangiapane, Alessandro Giammona, Adriana Cordova, Filippo Montemurro, Daniela Taverna, Maria Grazia Daidone, Giorgio Stassi, Silvia Giordano

Published Aug 6, 2019 · Vol. 10, No. 48 · pp. 5003-5004

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer Research Paper

Masafumi Iida, Misato Nakamura, Emi Tokuda, Daichi Toyosawa, Toshifumi Niwa, Noriaki Ohuchi, Takanori Ishida, Shin-ichi Hayashi

Published Aug 6, 2019 · Vol. 10, No. 47 · pp. 4907-4918

Keywords: breast cancer, CDK4/6 inhibitor, resistance, CDK6, p21

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer Research Paper

Sierra A. Colavito, James T. Platt, Matthew A. Held, Zongzhi Liu, Ryan Sokup, David F. Stern

Published Aug 6, 2019 · Vol. 10, No. 47 · pp. 4822-4839

Keywords: epithelial-mesenchymal transition, triple-negative breast cancer, targeted drug combination screen, claudin-low breast cancer, CHK1

Genomics applied to the treatment of breast cancer Review

Diaddin Hamdan, Thi Thuy Nguyen, Christophe Leboeuf, Solveig Meles, Anne Janin, Guilhem Bousquet

Published Jul 30, 2019 · Vol. 10, No. 46 · pp. 4786-4801

Keywords: constitutional genomics, genomics applied to treatment, genomics of breast cancer, molecular and histological classification, tumor heterogeneity

KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells Research Paper

Kengo Okamoto, Yuji Tanaka, Sachiko Ogasawara, Chikashi Obuse, Jun-ichi Nakayama, Hirohisa Yano, Makoto Tsuneoka

Published Jul 30, 2019 · Vol. 10, No. 46 · pp. 4743-4760

Keywords: HP1, KDM2A, nucleoli, rRNA, TNBC

CD9: A possible clue into breast cancer chemoresistance News

Natalia Pacienza, Gustavo Yannarelli

Published Jul 27, 2019 · Vol. 10, No. 48 · pp. 4921-4922

Keywords: breast cancer, chemoresistance, mesenchymal stem cells, CD9

CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer Research Paper

Elisabet Frick, Thorkell Gudjonsson, Jorunn Eyfjord, Jon Jonasson, Laufey Tryggvadóttir, Olafur Stefansson, Stefan Sigurdsson

Published Jul 23, 2019 · Vol. 10, No. 45 · pp. 4664-4678

Keywords: breast cancer, microRNA-190b, DNA methylation, prognosis, estrogen receptor

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Feng-Mao Lin, Susan E. Yost, Wei Wen, Paul H. Frankel, Daniel Schmolze, Pei-Guo Chu, Yate-Ching Yuan, Zheng Liu, John Yim, Zhen Chen, Yuan Yuan

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4356-4368

Keywords: AKT, differential expression, AKT targeting, TNBC

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Stephen L. Luen, Roberto Salgado, Sherene Loi

Published Jul 4, 2019 · Vol. 10, No. 45 · pp. 4612-4614

Keywords: triple negative breast cancer, tumor infiltrating lymphocytes, neoadjuvant chemotherapy, prognosis

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval Research Paper

Eva Ciruelos, Emilio Alba, Rafael López, Anna Lluch, Miguel Martín, Isabel Arroyo, Beatriz Navarro, David Carcedo, Ramón Colomer, Joan Albanell

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4321-4332

Keywords: early breast cancer, trastuzumab, life-years, economics, Spain

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia Research Paper

Anna Banach, Ya-Ping Jiang, Eric Roth, Cem Kuscu, Jian Cao, Richard Z. Lin

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4307-4320

Keywords: CEMIP, BiP, hypoxia, autophagy

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Research Paper

Minakshi Mann, Sachin Kumar, Shyam S. Chauhan, Neerja Bhatla, Sunesh Kumar, Sameer Bakhshi, Ritu Gupta, Ashok Sharma, Lalit Kumar

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4262-4275

Keywords: cervical cancer, cisplatin, PARP-1, PJ34, β-catenin

The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications Review

Cecilia Söderberg Nauclér, Jürgen Geisler, Katja Vetvik

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4333-4347

Keywords: human cytomegalovirus, HCMV, oncovirus, cancer, glioblastoma

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging Research Paper

Yuri Tolkach, Diane Goltz, Anika Kremer, Hojjat Ahmadzadehfar, Dominik Bergheim, Markus Essler, Marnix Lam, Bart de Keizer, Hans-Peter Fischer, Glen Kristiansen

Published Jun 25, 2019 · Vol. 10, No. 41 · pp. 4149-4160

Keywords: FOLH1, hepatocellular carcinoma, PET/CT, prostate-specific membrane antigen, theranostic

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Cathepsin L secretion by host and neoplastic cells potentiates invasion Research Paper

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database Clinical Research Papers

Nicotinamide in the prevention of breast cancer recurrences? Editorial

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer Research Paper

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis Research Perspective

Vascular endothelium function among male carriers of BRCA 1&2 germline mutation Research Paper

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy Correction

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer Research Paper

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer Research Paper

Genomics applied to the treatment of breast cancer Review

KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells Research Paper

CD9: A possible clue into breast cancer chemoresistance News

CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer Research Paper

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval Research Paper

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia Research Paper

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Research Paper

The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications Review

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Cathepsin L secretion by host and neoplastic cells potentiates invasion Research Paper

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database Clinical Research Papers

Nicotinamide in the prevention of breast cancer recurrences? Editorial

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer Research Paper

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis Research Perspective

Vascular endothelium function among male carriers of BRCA 1&2 germline mutation Research Paper

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy Correction

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer Research Paper

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer Research Paper

Genomics applied to the treatment of breast cancer Review

KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells Research Paper

CD9: A possible clue into breast cancer chemoresistance News

CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer Research Paper

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval Research Paper

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia Research Paper

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Research Paper

The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications Review

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging Research Paper